The present article reviews the evidence that melatonin possesses slee
p-inducing effects and that it gates the increase in nocturnal sleepin
ess. It is shown that, without exception, all the studies that have in
vestigated daytime administrations of melatonin reported increased sle
epiness, even at doses that do not increase plasma levels of melatonin
beyond its physiological levels. By contrast, nighttime increase in s
leepiness was achieved only after administration of high doses. Based
on these findings and on the precise coupling between the endogenous n
octurnal increase in melatonin secretion and the opening of the sleep
gate, it is suggested that melatonin participates in the regulation of
the sleep-wake cycle by inhibiting the central nervous system wakeful
ness generating system. This inhibition allows a smooth transition fro
m wakefulness to sleep. Clinical findings on decreased levels of noctu
rnal melatonin in chronic insomniacs, and on the efficacy of exogenous
melatonin in improving sleep in melatonin-deficient insomniacs, are c
ongruent with this hypothesis.